Overview
Calcium antagonist therapy is a type of medical treatment used to lower blood pressure and reduce the risk of stroke and coronary artery disease. Calcium channel blockers (CCBs) are the type of drug most commonly used during calcium antagonist therapy. These drugs act by blocking the flow of calcium ions into the cells of the heart and blood vessels, which relaxes the muscles in these tissues and reduces the pressure within them. This can help to lower overall systemic blood pressure and reduce the strain on the heart, reducing risk of stroke and coronary artery disease. Calcium antagonist therapy is an important tool for treating high blood pressure and reducing the risk of cardiovascular disease.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.
How this research is being cited
The 1 article above has been cited 22 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Journal of Applied Toxicology
-
Yuping Zhang et al. · 2025 · Biomaterials
-
Rupam Saha et al. · 2025 · Medicine in Novel Technology and Devices
-
2025 · Medicine in Novel Technology and Devices
-
2025 · Biomaterials
-
2025 · Journal of Applied Toxicology
-
Hajin Kim et al. · 2024 · Electronics
-
2024 · Electronics
A sample of recent works citing this journal's research on Calcium Antagonist Therapy, linking to each citing work.